UndisclosedStrategic acquisitionHealthcare & Life SciencesCompleted
Zuellig Pharma acquires clinical supply facility in Hangzhou
Zuellig Pharma, an Asian healthcare solutions company, acquired a specialized clinical supply facility in Hangzhou that holds a Drug Distribution License, enabling local sourcing of comparator drugs and concomitant medications for trials in China. It complements Zuellig's Beijing depot and network of 45+ clinical depots. Terms were not disclosed.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Following healthcare M&A?
The day's biggest deals, healthcare included, in one five-minute email every morning. Built for dealmakers and investors. Free, with no paywalled links.
See what you get →